bias_variance

TL4 Biostatistician · Aarhus, DK

Biostatistician. I am the person who asks what the estimand was. Sorry in advance.

Joined 12 May 2024 · last posted 2h · groups: journal-club, trust-level-4

224 posts, newest first. Showing up to 150.

GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #54 · Compounds › Secretagogues & GH axis · 28 Jul 2026 · 4 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
What to bring: records that a clinician can actually use — a second dataset Replied, post #83 · Clinical › Prescriber conversations · 27 Jul 2026 · 30 likes A second opinion is a normal part of medicine rather than an accusation, and asking how to obtain one is a legitimate question. I have no interest in any supplier named…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #73 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 0 likes Detection wavelength is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Common supplements people ask about, assessed one at a time Replied, post #87 · Practice › Interactions · 23 Jul 2026 · 2 likes Anyone asking an interaction question should list everything, including the things they consider irrelevant. The irrelevant one is the answer more often than chance…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #18 · Compounds › Oral incretins · 23 Jul 2026 · 4 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Seven-day rolling means and why weekly readings mislead Replied, post #65 · Outcomes › Progress reports · 20 Jul 2026 · 28 likes I read post #62 twice before replying, because I had assumed the opposite. A single scale used throughout beats a more accurate scale introduced halfway through.…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #65 · Compounds › Retatrutide · 15 Jul 2026 · 4 likes If someone has run retatrutide discussion properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Second pass at: When your prescriber and the evidence disagree Replied, post #50 · Clinical › Prescriber conversations · 14 Jul 2026 · 0 likes My position on prescriber is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Immortal time bias in a claims-database study — one year on Replied, post #23 · Evidence › Study critique · 14 Jul 2026 · 3 likes Adding a small correction to the Immortal time bias summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #77 · Analytics › Impurities & related substances · 14 Jul 2026 · 25 likes Reporting thresholds matter: below a stated threshold, peaks are usually not reported at all. A clean-looking table may reflect a high threshold rather than a clean…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #42 · Start Here › Welcome · 14 Jul 2026 · 8 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
Submitting a sample: the process end to end Replied, post #77 · Sourcing › Independent verification · 12 Jul 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #10 · Analytics › COA interpretation · 12 Jul 2026 · 3 likes Post #8 put the caveat in the right place and I want to underline it. If someone has run Batch date properly I would rather read that than my own reconstruction of it.…
Packaging that arrived damaged: documenting it properly Replied, post #38 · Sourcing › Logistics · 7 Jul 2026 · 23 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing.
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #17 · Clinical › Bloodwork · 7 Jul 2026 · 31 likes Where I part company with post #13, and it is a narrow parting. The honest answer on HbA1c lag is that it depends, and the useful part is the list of what it depends…
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #17 · Clinical › Comorbidities · 7 Jul 2026 · 31 likes This follows post #16 rather than contradicting it. Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are…
Personal or family history of medullary thyroid carcinoma Replied, post #31 · Safety › Contraindications · 30 Jun 2026 · 21 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #15 · Compounds › Secretagogues & GH axis · 29 Jun 2026 · 22 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #33 · Analytics › Impurities & related substances · 29 Jun 2026 · 32 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #50 · Compounds › Repair & healing peptides · 28 Jun 2026 · 7 likes I would call the community position on absence of controlled human data likely rather than established, and I would be comfortable defending that hedge.
Pages past their review date, listed — does this still hold? Replied, post #28 · Meta › Wiki maintenance · 27 Jun 2026 · 0 likes Practical answer on Pages past, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #39 · Access › International · 27 Jun 2026 · 0 likes Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.
Why a pen's dose steps are fixed and what that costs you Replied, post #2 · marked as the solution · Devices › Pens & autoinjectors · 24 Jun 2026 · 25 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
Coming back to: A structured critique template this community uses Replied, post #37 · Evidence › Study critique · 19 Jun 2026 · 4 likes On post #35 — agreed on the reasoning, with one qualification. Statistical significance and clinical importance are different and both are needed. A significant…
Splitting an overlong document into two Replied, post #26 · Documentation › Wiki requests · 17 Jun 2026 · 0 likes Everything in post #25 holds. The case it does not cover is the one I have. Source for the splitting an overlong document figure, since it was asked for. It is in the…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #78 · Compounds › Semaglutide · 14 Jun 2026 · 3 likes Answering the question post #76 raises rather than the one it answers. On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #128 · Practice › Storage & stability · 10 Jun 2026 · 0 likes Post #127 is right about the mechanism and I think understates the practical bit. Practical note on reconstituted: write down what you expect before you look. The…
Second pass at: Absence of evidence and evidence of absence Replied, post #17 · Research Methods › Statistics · 7 Jun 2026 · 29 likes I read the earlier replies on Absence of evidence twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was…
Reading a trial's population section before its results Replied, post #89 · Evidence › Trials · 5 Jun 2026 · 27 likes Post #87 is the version of this I will quote in future. One addition. Registration before enrolment, with the primary endpoint declared, is what makes outcome switching…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #89 · Sourcing › Logistics · 2 Jun 2026 · 7 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #82 · Practice › Reconstitution · 31 May 2026 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
Does dual agonism explain the effect size, or is it dose? Replied, post #8 · Compounds › Tirzepatide · 30 May 2026 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #14 · Compounds › Semaglutide · 28 May 2026 · 2 likes Post #10 describes the usual case. This is about the unusual one. On the injection-day question: the labelling for licensed semaglutide allows the day to be changed…
What to include when your question involves a chromatogram — one year on Replied, post #17 · Start Here › How to Ask · 27 May 2026 · 6 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
The anatomy of a question that gets answered within an hour Replied, post #57 · Start Here › How to Ask · 26 May 2026 · 26 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #67 · Practice › Reconstitution · 23 May 2026 · 13 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Two scans six weeks apart on different machines: a cautionary tale Replied, post #22 · Outcomes › Body composition · 20 May 2026 · 0 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly. That is…
Transporting a vial for a weekend away — a second dataset Replied, post #55 · Practice › Storage & stability · 17 May 2026 · 2 likes An observation about Transporting a vial that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
A checklist for reading a certificate in under two minutes Replied, post #22 · Analytics › COA interpretation · 16 May 2026 · 6 likes A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing.…
Reading a trial's population section before its results Replied, post #10 · Evidence › Trials · 10 May 2026 · 28 likes Safety findings from a trial powered for efficacy are underpowered by construction. Absence of a signal in that setting is weak evidence of absence.
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #33 · Compounds › Tirzepatide · 8 May 2026 · 1 like Confirming post #32 from a second method, which matters more than confirming it from a second person. Categorical response thresholds — the proportion reaching ten,…
How shortages have affected compounding permissions — does this still hold? Started this topic · Access › Shortages · 6 May 2026 · 3 likes How shortages have affected compounding permissions — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked.…
About the Insurance & coverage category Replied, post #6 · Access › Insurance & coverage · 5 May 2026 · 5 likes Post #5 is the version of this I will quote in future. One addition. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #43 · Sourcing › Independent verification · 2 May 2026 · 10 likes Answering the question post #39 raises rather than the one it answers. One more thing on Janoshik that took me far too long to see: the two figures people quote are not…
Anaesthesia and elective surgery: the aspiration question Replied, post #106 · Practice › Interactions · 30 Apr 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Molecular mass of semaglutide and why the figure differs between sources Replied, post #45 · Compounds › Semaglutide · 28 Apr 2026 · 8 likes Answering the question post #41 raises rather than the one it answers. The mass figure differs between sources because of how the different entities report it. The…
Two scans six weeks apart on different machines: a cautionary tale Replied, post #7 · marked as the solution · Outcomes › Body composition · 27 Apr 2026 · 7 likes Two scans six months apart on one machine tell you something. Two scans six weeks apart on different machines tell you about the machines. Old habit: I write down the…
About the Interactions category Replied, post #6 · Practice › Interactions · 22 Apr 2026 · 18 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #80 · Analytics › Mass spectrometry · 14 Apr 2026 · 19 likes I would rather this thread reach "we do not know" about Charge states than reach a confident answer that nobody can support when asked.
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #2 · Analytics › Impurities & related substances · 13 Apr 2026 · 17 likes Relative response factors mean impurities are not detected in proportion to how much of them is present. A one per cent peak is not one per cent by mass unless the…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #105 · Clinical › Special populations · 10 Apr 2026 · 7 likes Pregnancy and breastfeeding are the clearest cases where the answer is that the trials excluded them and the labelling reflects that exclusion. If it helps: the failure…
Spike-and-recover accuracy for a peptide assay Replied, post #31 · Analytics › Method validation · 7 Apr 2026 · 15 likes Coming back to post #27, because the follow-up matters more than the original answer. The limit of quantitation determines what the impurity table can honestly contain.…
Follow-up: State-level differences that actually matter Replied, post #48 · Regional › North America · 6 Apr 2026 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Revisiting: Drawing up with one needle and injecting with another Replied, post #14 · Practice › Administration · 1 Apr 2026 · 5 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. A…
The "under review" status pill and when a moderator applies it Replied, post #41 · Evidence › Preprints · 28 Mar 2026 · 17 likes Taking post #40 at face value and following it one step further. The honest position on most preprints in this field is that they are interesting and provisional, and…
The anatomy of a question that gets answered within an hour Replied, post #5 · Start Here › How to Ask · 26 Mar 2026 · 1 like A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. The interesting part of this is the…
Named, unnamed and unspecified impurities as regulatory categories Replied, post #10 · Analytics › Impurities & related substances · 21 Mar 2026 · 12 likes Where I part company with post #8, and it is a narrow parting. Oxidation at methionine or tryptophan adds sixteen per oxygen and typically elutes earlier. In aged…
The "under review" status pill and when a moderator applies it Replied, post #16 · Evidence › Preprints · 11 Mar 2026 · 1 like A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties. It took…
A plateau that disappeared when I changed how I measured Replied, post #22 · Outcomes › Progress reports · 10 Mar 2026 · 24 likes Thank you — that answers what I came here to find out.
The lowest dose that does anything: is that a real question? Replied, post #109 · Practice › Dosing & titration · 8 Mar 2026 · 4 likes Answering the question post #107 raises rather than the one it answers. Holding at a dose that is working is a legitimate position and it is not what the trial…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #5 · Evidence › Preprints · 3 Mar 2026 · 0 likes Adding a data point of agreement rather than a data point.
[2026 update] What a purity-only report leaves out Replied, post #38 · Sourcing › Independent verification · 28 Feb 2026 · 27 likes Worth separating two things that post #36 runs together. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #55 · Clinical › Special populations · 26 Feb 2026 · 0 likes On pregnancy and pregnancy planning I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #38 · Evidence › Trials · 25 Feb 2026 · 0 likes I would call the community position on Non-inferiority margins likely rather than established, and I would be comfortable defending that hedge.
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #100 · Documentation › Wiki requests · 21 Feb 2026 · 10 likes That reframing is the whole thing. The facts I already had.
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #12 · Compounds › Repair & healing peptides · 20 Feb 2026 · 0 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #9 · Analytics › Method validation · 20 Feb 2026 · 20 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #67 · Practice › Dosing & titration · 18 Feb 2026 · 4 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #38 · Practice › Dosing & titration · 17 Feb 2026 · 8 likes The starting dose in most of these programmes is a tolerance step and produces little effect by design. Judging the compound at the starting dose is judging the wrong…
Amylin receptor signalling and satiety — what changed since Replied, post #31 · Pharmacology › Receptor biology · 16 Feb 2026 · 2 likes Noted, and thank you for writing it out rather than summarising it.
[2026 update] Confounding by indication, explained with a concrete example Replied, post #56 · Evidence › Study critique · 15 Feb 2026 · 5 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
Mass error in ppm: the arithmetic and the caveat Replied, post #106 · Analytics › Mass spectrometry · 15 Feb 2026 · 16 likes Where I part company with post #104, and it is a narrow parting. For anyone finding this later: the short answer on mass error in ppm is that it depends on one thing,…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #110 · Access › International · 15 Feb 2026 · 11 likes Appreciated. The plain phrasing does more work here than a longer post would.
Second pass at: Metformin co-administration and additive GI effects Replied, post #50 · Practice › Interactions · 15 Feb 2026 · 0 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
Travelling with an injectable: documentation and practicalities Replied, post #10 · Access › International · 11 Feb 2026 · 1 like Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #4 · Meta › Announcements · 10 Feb 2026 · 7 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Reframing Trust level 3 requirements slightly, because I think the…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #65 · Compounds › Semaglutide · 9 Feb 2026 · 14 likes Saving this. It is the version I will quote when the question comes round again.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #102 · Clinical › Special populations · 26 Jan 2026 · 18 likes An update on my earlier Pregnancy and pregnancy planning post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #85 · Clinical › Special populations · 25 Jan 2026 · 1 like Where the Pregnancy and pregnancy planning discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are…
Constipation management, with a dietitian's contribution Replied, post #21 · Practice › Side effects · 20 Jan 2026 · 5 likes Post #18 is the version of this I will quote in future. One addition. Constipation management looks different depending on whether you are reading the primary…
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #5 · Compounds › Repair & healing peptides · 20 Jan 2026 · 5 likes This follows post #4 rather than contradicting it. Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both…
MHRA statements, read directly Replied, post #68 · Regional › UK & Ireland · 14 Jan 2026 · 0 likes A methods point on MHRA statements rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Follow-up: Reconciling a label claim with a content assay Replied, post #2 · Analytics › COA interpretation · 10 Jan 2026 · 18 likes Adding the measurement that the opening post says would settle it. What I would check first on Reconciling a label claim is whether the thing being measured moved or…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #48 · Clinical › Bloodwork · 10 Jan 2026 · 0 likes On post #44 — agreed on the reasoning, with one qualification. Reading this panel thread as someone who came in with a fixed view: the third and seventh replies moved…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #11 · Clinical › Special populations · 10 Jan 2026 · 0 likes I changed my mind about pregnancy and pregnancy planning after someone here asked me for the source and I could not produce one. That is worth saying out loud because…
Personal import allowances, compared — a second dataset Replied, post #48 · Access › International · 7 Jan 2026 · 13 likes The arithmetic in post #45 is right; the assumption feeding it is the part to check. If someone has run Personal import allowances properly I would rather read that…
Request: export my own posts — one year on Replied, post #30 · Meta › Feature requests · 4 Jan 2026 · 0 likes That would be genuinely useful in the vendor pages too, where a discussion link often means posts eleven through fifteen and points at eleven.
A single out-of-range value on an otherwise normal panel Replied, post #2 · Clinical › Bloodwork · 30 Dec 2025 · 0 likes Answering the question the opening post raises rather than the one it answers. I keep a log for single out-of-range value specifically because my memory of it turned…
Vomiting: when it is expected and when it is a reason to stop Replied, post #116 · Practice › Side effects · 30 Dec 2025 · 9 likes Where I part company with post #114, and it is a narrow parting. Tracking severity on a simple scale with dates is far more useful than describing it afterwards. Memory…
Heterogeneity as information rather than as a nuisance Replied, post #22 · Evidence › Meta-analyses · 11 Dec 2025 · 0 likes Coming back to post #20, because the follow-up matters more than the original answer. If someone has run heterogeneity properly I would rather read that than my own…
Reused chromatograms across lots: how to spot it Replied, post #7 · Analytics › COA interpretation · 8 Dec 2025 · 0 likes An honest declaration on reused chromatograms across lots: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #31 · Devices › Pens & autoinjectors · 5 Dec 2025 · 0 likes Post #30 put the caveat in the right place and I want to underline it. Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is…
Can a home kit substitute for a laboratory report? A careful no Replied, post #68 · Analytics › Home & field testing · 2 Dec 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
What pooling buys you and what it destroys Replied, post #75 · Evidence › Meta-analyses · 25 Nov 2025 · 1 like A note on how pooling buys gets discussed rather than on pooling buys itself: the confident posts get the replies and the careful ones get ignored, and the careful ones…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #69 · Compounds › Other compounds · 25 Nov 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed Sequence verification, as opposed to read about it? The thread is long and I cannot tell.
Coverage in the US: a map of the usual obstacles Replied, post #14 · Regional › North America · 23 Nov 2025 · 13 likes Answering the coverage question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
DXA precision and the least significant change for lean mass Replied, post #9 · Outcomes › Body composition · 20 Nov 2025 · 20 likes Neither method is capable of detecting the month-to-month changes that people report detecting month to month.
[2026 update] What steady state means for the decision to escalate Replied, post #92 · Practice › Dosing & titration · 14 Nov 2025 · 17 likes I read post #90 twice before replying, because I had assumed the opposite. Offering a way to settle steady state rather than another opinion about it. Two measurements,…
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #25 · Sourcing › Regulatory · 11 Nov 2025 · 6 likes On Pharmaceutical compounding rules I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating…
The anatomy of a question that gets answered within an hour — the long version Replied, post #52 · Start Here › How to Ask · 2 Nov 2025 · 2 likes Post #48 and I disagree about the size of the effect, not about the direction. If the answer you got does not fit your case, say which part does not fit rather than…
Thyroid function tests during substantial weight change Replied, post #109 · Clinical › Bloodwork · 25 Oct 2025 · 3 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
Second pass at: The mass-error checker and its intended scope Replied, post #46 · Data & Tools › Calculators · 24 Oct 2025 · 5 likes Post #42 describes the usual case. This is about the unusual one. A note on scope: what I am saying about mass-error checker applies to the case in the first post and I…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #107 · Start Here › Welcome · 22 Oct 2025 · 1 like If you are not sure which subcategory a question belongs in, post it in the closest one. A moderator will move it, the move is logged, and nothing bad happens to you.…
Sleep quality changes during weight loss — what changed since Replied, post #33 · Wellbeing › Sleep · 20 Oct 2025 · 0 likes Post #32 is the version of this I will quote in future. One addition. Any objective measurement, even an imprecise one, beats a recollection when the question is…
What pooling buys you and what it destroys Replied, post #44 · Evidence › Meta-analyses · 17 Oct 2025 · 2 likes Sensible. I would want the same detail before I acted on it either.
Revisiting: Gallbladder disease risk with rapid weight loss Started this topic · Clinical › Comorbidities · 9 Oct 2025 · 0 likes Revisiting: Gallbladder disease risk with rapid weight loss Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #40 · Compounds › Tirzepatide · 9 Oct 2025 · 12 likes Adding a null result on dual agonism. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
What pooling buys you and what it destroys Replied, post #35 · Evidence › Meta-analyses · 4 Oct 2025 · 2 likes Something worth flagging about pooling buys: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
What a purity-only report leaves out Replied, post #32 · Sourcing › Independent verification · 2 Oct 2025 · 0 likes I would put moderate confidence on the mainstream reading of purity-only and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #40 · Analytics › COA interpretation · 23 Sep 2025 · 6 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #49 · Lounge › Off topic · 21 Sep 2025 · 27 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. That is the version I use. It may not…
Substitution between formats during a shortage Replied, post #60 · Access › Shortages · 20 Sep 2025 · 6 likes Taking post #59 at face value and following it one step further. Shortage-driven price movement is real and is a separate question from availability. The conclusion is…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #120 · Access › Insurance & coverage · 15 Sep 2025 · 20 likes Where an exception process exists separately from an appeal, they are different routes with different criteria and using the wrong one loses time.
A ten-fold dose error caught before injection Replied, post #98 · Devices › Syringes & needles · 11 Sep 2025 · 2 likes I had written a reply contradicting post #94 and deleted it. Here is what survived. Drawing air into the vial before withdrawing liquid equalises the pressure and makes…
Pinch or no pinch, and how needle length changes the answer Replied, post #56 · Practice › Administration · 11 Sep 2025 · 0 likes Bleeding at the site is common and unremarkable at these needle gauges. Persistent bruising in the same area repeatedly is worth a change of technique or of site rather…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #122 · Data & Tools › Datasets · 10 Sep 2025 · 1 like I would rather this thread reach "we do not know" about Aggregated purity results across four than reach a confident answer that nobody can support when asked.
Which panel is worth repeating and which is worth ignoring Replied, post #107 · Clinical › Bloodwork · 10 Sep 2025 · 0 likes My experience of panel contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
Can a home kit substitute for a laboratory report? A careful no Replied, post #9 · marked as the solution · Analytics › Home & field testing · 9 Sep 2025 · 7 likes Counterpoint on home kit substitute, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Pooling trials with different estimands — what changed since Replied, post #20 · Evidence › Meta-analyses · 3 Sep 2025 · 0 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #6 · Evidence › Journal club · 31 Aug 2025 · 21 likes What I would want before treating step-hfpef and symptom endpoints as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the…
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #29 · Compounds › Tirzepatide · 28 Aug 2025 · 0 likes Answering the question post #25 raises rather than the one it answers. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #53 · Evidence › Journal club · 28 Aug 2025 · 2 likes What I can speak to on orforglipron phase 2 is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #44 · Evidence › Journal club · 24 Aug 2025 · 33 likes Worth separating two things that post #43 runs together. The claim about orforglipron phase 2 upthread is stronger than its source supports. I have read the source. The…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #11 · Practice › Side effects · 23 Aug 2025 · 10 likes My experience of nausea timeline contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #45 · Practice › Reconstitution · 19 Aug 2025 · 11 likes On a U-100 insulin syringe, one hundred units is one millilitre and one unit is 0.01 millilitres. Units are volume marks. They mean nothing until you know the…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #40 · Analytics › HPLC & UHPLC · 18 Aug 2025 · 0 likes Post #39 is right about the mechanism and I think understates the practical bit. Resolution and tailing factor is one of those subjects where the general answer and the…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #17 · Compounds › Other compounds · 11 Aug 2025 · 0 likes On post #15 — agreed on the reasoning, with one qualification. Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #15 · Evidence › Journal club · 11 Aug 2025 · 6 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. That is the version I use. It may not be the version…
A request that was declined, and the reasoning — a second dataset Replied, post #10 · Documentation › Wiki requests · 5 Aug 2025 · 2 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. Link the topics that prompted the request. The discussion is the…
How to research a compound with no human data without deceiving yourself Replied, post #89 · Compounds › Other compounds · 3 Aug 2025 · 18 likes The practical version of research a compound is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
When a preprint is the best available evidence and we say so Replied, post #18 · Evidence › Preprints · 2 Aug 2025 · 31 likes The arithmetic in post #17 is right; the assumption feeding it is the part to check. Reading a preprint properly means doing some of the reviewer's job: methods first,…
Revisiting: List price versus negotiated price versus what you pay Replied, post #2 · Access › Pricing · 1 Aug 2025 · 7 likes Nothing to add on the substance. Thank you for taking the question at face value.
"Should I double up?" — answered once, at length, calmly Replied, post #8 · Practice › Administration · 23 Jul 2025 · 32 likes Post #7 is the version of this I will quote in future. One addition. If you have to inject at a different time of day than usual, that is a much smaller perturbation…
Canadian access and provincial variation — one year on Replied, post #9 · Regional › North America · 20 Jul 2025 · 0 likes Post #6 describes the usual case. This is about the unusual one. Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a…
Meeting a protein target on a suppressed appetite Replied, post #10 · Nutrition & Training › Protein & intake · 16 Jul 2025 · 0 likes A target that is not being met is worth adjusting downward to something achievable rather than being missed indefinitely.
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #20 · Analytics › Mass spectrometry · 12 Jul 2025 · 25 likes I read post #19 twice before replying, because I had assumed the opposite. Resolution and mass accuracy are different specifications. An instrument can resolve two…
Temperature loggers worth the money — the long version Replied, post #9 · Devices › Cold chain · 8 Jul 2025 · 6 likes Following this. I have the same question and no better information than the first post.
Reconstituting a multi-strength kit without mixing yourself up Replied, post #94 · Practice › Reconstitution · 2 Jul 2025 · 16 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Repeatability versus intermediate precision Replied, post #77 · Analytics › Method validation · 27 Jun 2025 · 14 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it.
A ten-fold dose error caught before injection Replied, post #54 · Devices › Syringes & needles · 24 Jun 2025 · 6 likes Where I part company with post #50, and it is a narrow parting. Offering a way to settle ten-fold dose error caught rather than another opinion about it. Two…
Repeatability versus intermediate precision Replied, post #28 · Analytics › Method validation · 21 Jun 2025 · 9 likes I had read the opposite somewhere and cannot now find where, which tells me something.
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 18 Jun 2025 · 29 likes On post #53 — agreed on the reasoning, with one qualification. Worth distinguishing the combination product from the two components bought separately and mixed. Those…
Anxiety in the first weeks: drug, situation, or both — what changed since Started this topic · Wellbeing › Mental health · 16 Jun 2025 · 1 like Anxiety in the first weeks: drug, situation, or both — what changed since Writing it up because I had to work it out twice and would rather nobody else did. The…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #99 · Nutrition & Training › Protein & intake · 15 Jun 2025 · 6 likes The arithmetic in post #98 is right; the assumption feeding it is the part to check. What I would check first on Tracking intake is whether the thing being measured…
[2026 update] An appeal that failed, and what I would do differently Replied, post #100 · Access › Insurance & coverage · 13 Jun 2025 · 2 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #107 · Compounds › Tirzepatide · 11 Jun 2025 · 0 likes The bit of tirzepatide in type 2 diabetes that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #83 · Practice › Reconstitution · 9 Jun 2025 · 1 like Thank you — that answers what I came here to find out.
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #47 · Evidence › Journal club · 8 Jun 2025 · 5 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
Coming back to: Getting a referral rather than a refusal Replied, post #44 · Clinical › Prescriber conversations · 8 Jun 2025 · 0 likes I had written a reply contradicting post #42 and deleted it. Here is what survived. Where I would push back on the Getting a referral consensus is the confidence, not…
Anxiety in the first weeks: drug, situation, or both Replied, post #98 · Wellbeing › Mental health · 5 Jun 2025 · 0 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.